[The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
100 cases of uveal melanomas, were treated with 106RU 106RH beta-brachytherapy, between June 1983 and September 1987. 82 eyes having a follow-up superior or equal to 12 months, were analysed. 13 of these 82 eyes have been enucleated. 4 patients have died. 3 have at this time, hepatic dissemination. The first 43 patients were analysed at the 18th month after irradiation. The majority of tumors with initial thickness inferior to 5 mm had a regression superior to 50%, at the 18th month. The majority of tumors with initial thickness superior to 5 mm, had a regression inferior to 50%, at the same time. Functional results have also been noticed in this series of 43 eyes, and were satisfactory.
Grange
J D
JD
Gérard
J P
JP
Ragab
M
M
Delaroche
G
G
Jean-Louis
B
B
Bievelez
B
B
Sentenac
I
I
Baute
B
B
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy; D002830:Choroid Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D002924:Ciliary Body; D015353:Eye Enucleation; D006801:Humans; D008545:Melanoma / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D008875:Middle Aged; D011829:Radiation Dosage; D014604:Uveal Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
Place de la bêtacuriethérapie de contact dans le traitement des mélanomes de la choroïde et du corps ciliaire.